EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuromuscular junction dysfunction in Lafora disease

Monica Shukla, Deepti Chugh, Subramaniam Ganesh iD

Disease Models & Mechanisms · 01.10.2024 · 17 (10)

DOI: 10.1242/dmm.050905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 14.10.2024. Verfasst von Monica Shukla und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India. Hauptthemen laut MEDLINE: Lafora Disease, Neuromuscular Junction, Protein Tyrosine Phosphatases, Non-Receptor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Engineering Research Board, Ministry of Education, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lafora disease (LD), a fatal neurodegenerative disorder, is caused by mutations in the EPM2A gene encoding laforin phosphatase or NHLRC1 gene encoding malin ubiquitin ligase. LD symptoms include epileptic seizures, ataxia, dementia and cognitive decline. Studies on LD have primarily concentrated on the pathophysiology in the brain. A few studies have reported motor symptoms, muscle weakness and muscle atrophy. Intriguingly, skeletal muscles are known to accumulate Lafora polyglucosan bodies. Using laforin-deficient mice, an established model for LD, we demonstrate that LD pathology correlated with structural and functional impairments in the neuromuscular junction (NMJ). Specifically, we found impairment in NMJ transmission, which coincided with altered expression of NMJ-associated genes and reduced motor endplate area, fragmented junctions and loss of fully innervated junctions at the NMJ. We also observed a reduction in alpha-motor neurons in the lumbar spinal cord, with significant presynaptic morphological alterations. Disorganised myofibrillar patterns, slight z-line streaming and muscle atrophy were also evident in LD animals. In summary, our study offers insight into the neuropathic and myopathic alterations leading to motor deficits in LD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lafora DiseaseNeuromuscular JunctionProtein Tyrosine Phosphatases, Non-ReceptorAnimalsMiceUbiquitin-Protein LigasesMotor NeuronsSynaptic TransmissionMyofibrilsSpinal CordMuscle, SkeletalDisease Models, Animal

Stichwörter der Autor:innen

Autophagy defectGlycogen storage diseaseMetabolic disordersNeurodegenerative disorderProgressive myoclonus epilepsy

Substanzen

Protein Tyrosine Phosphatases, Non-ReceptorEpm2a protein, mouseUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
  • Mehta Family Centre for Engineering in Medicine, Indian Institute of Technology, Kanpur 208016, India.
  • Gangwal School of Medical Sciences and Technology, Indian Institute of Technology, Kanpur 208016, India.

ORCID-Profile: Subramaniam Ganesh

Förderung

  • Science and Engineering Research Board
  • Ministry of Education, India

Zitieren

APA

Shukla, M., Chugh, D., & Ganesh, S. (2024). Neuromuscular junction dysfunction in Lafora disease. Disease Models & Mechanisms, 17(10). https://doi.org/10.1242/dmm.050905

Vancouver

Shukla M, Chugh D, Ganesh S. Neuromuscular junction dysfunction in Lafora disease. Disease Models & Mechanisms. 2024;17(10). doi:10.1242/dmm.050905

BibTeX
@article{Shukla2024,
  author = {Shukla, Monica and Chugh, Deepti and Ganesh, Subramaniam},
  title = {Neuromuscular junction dysfunction in Lafora disease},
  journal = {Disease Models & Mechanisms},
  year = {2024},
  volume = {17},
  number = {10},
  doi = {10.1242/dmm.050905}
}
Kostenlos starten →